PMID: 11311898Apr 20, 2001Paper

Tetrahydrocannabinol-induced apoptosis of cultured cortical neurones is associated with cytochrome c release and caspase-3 activation

Neuropharmacology
Veronica A Campbell

Abstract

Delta(9)-tetrahydrocannabinol (THC), the principal psychoactive component of marijuana, is associated with impaired cognition and altered cortical function. THC transduces its central effects via activation of the G-protein linked cannabinoid receptor CB1. In this study we report that THC induces morphological degenerative changes in cultured cortical neurones, such as membrane blebbing and formation of apoptotic bodies, that are consistent with the apoptotic pathway of cell death. The THC-induced apoptosis was blocked by the CB1 receptor antagonist AM251 and pertussis toxin (PTX), suggesting that this effect of THC involves receptor-mediated activation of the G-protein subtypes G(i) or G(o). THC also promoted translocation of mitochondrial cytochrome c to the cytosol and increased the activity of the cysteine protease caspase-3, in a PTX-sensitive manner. The results from this study suggest that coupling of THC to a PTX-sensitive G-protein promotes cytochrome c release, caspase-3 activation and subsequent degeneration of cultured cortical neurones. This apoptotic pathway may underlie the compromised neuronal function that is associated with marijuana usage.

References

May 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·K Mackie, B Hille
Oct 1, 1990·Trends in Pharmacological Sciences·A C Howlett
Apr 1, 1990·Journal of Developmental and Behavioral Pediatrics : JDBP·P A Fried, B Watkinson
Aug 1, 1984·Clinical Pharmacology and Therapeutics·C W Chiang, G Barnett
Dec 1, 1980·Drug and Alcohol Dependence·P A Fried
Jan 1, 1995·Annual Review of Pharmacology and Toxicology·A C Howlett
Mar 1, 1995·Trends in Genetics : TIG·S J Korsmeyer
Jan 1, 1993·Psychopharmacology·R I Block, M M Ghoneim
Jun 1, 1994·Current Opinion in Neurobiology·T Reisine, M J Brownstein
Sep 27, 1996·Biochemical Pharmacology·S R Childers, S A Deadwyler
Jun 1, 1997·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·J D JentschR H Roth
Jan 1, 1997·Life Sciences·R J MathewT R DeGrado
Mar 21, 1998·Pharmacology & Therapeutics·M Raffray, G M Cohen
May 23, 1998·The Journal of Physiology·I FarkasH Okada
May 23, 1998·The Journal of Biological Chemistry·R U JänickeA G Porter
Oct 15, 1998·FEBS Letters·C SánchezM Guzmán
Feb 3, 1999·Annals of the New York Academy of Sciences·M B HamptonS Orrenius
Mar 4, 2000·Brain Research·D F LouwG R Sutherland
Apr 6, 2000·The Biochemical Journal·T Gómez del PulgarM Guzmán
Jun 17, 2000·The Journal of Biological Chemistry·E VerekerM A Lynch
Jul 26, 2000·The Journal of Cell Biology·S GhatanR S Morrison

❮ Previous
Next ❯

Citations

Nov 28, 2007·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Allyn C HowlettDerek C Norford
Dec 3, 2014·Pharmacology & Therapeutics·Dan I LubmanMurat Yücel
Jul 14, 2010·Progress in Neurobiology·Matthijs G Bossong, Raymond J M Niesink
May 7, 2004·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Ibolja CernakAlan I Faden
Oct 14, 2008·Annales pharmaceutiques françaises·J Costentin
Oct 16, 2010·Neuropathology and Applied Neurobiology·A Büttner
Jun 17, 2011·Birth Defects Research. Part B, Developmental and Reproductive Toxicology·Arnab BanerjeeAmitabh Krishna
Jan 19, 2010·Drug and Alcohol Review·Eric J Downer, Veronica A Campbell
Dec 5, 2006·Brain Research·Glenna L GilbertStanley A Thayer
Oct 2, 2004·Physical Medicine and Rehabilitation Clinics of North America·Gregory T Carter, Vivian Ugalde
Jan 9, 2013·Journal of Applied Toxicology : JAT·Panagiotis ZogopoulosStamatios Theocharis
Jun 8, 2002·Prostaglandins, Leukotrienes, and Essential Fatty Acids·Daniela ParolaroE Monti
Sep 2, 2017·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Arnau Busquets-GarciaGiovanni Marsicano
Sep 19, 2002·Molecular Pharmacology·Sophie Parmentier-BatteurDavid A Greenberg
Nov 22, 2005·Molecular Pharmacology·Sun Hee KimDavid A Greenberg
Jul 20, 2002·The Journal of Pharmacology and Experimental Therapeutics·Robert J McKallipPrakash S Nagarkatti
Jan 21, 2003·American Journal of Physiology. Lung Cellular and Molecular Physiology·Theodore A SarafianMichael D Roth
Jan 29, 2003·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Wei PeiJun Chen
Sep 26, 2020·Molecular Psychiatry·Deepak Cyril D'SouzaPatrick Skosnik
Nov 18, 2003·The Journal of Pharmacology and Experimental Therapeutics·Paola MassiDaniela Parolaro
Aug 6, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Yoonkyung DoPrakash S Nagarkatti
Jan 1, 2021·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·Lin YeYan Jiang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptotic Caspases

Apoptotic caspases belong to the protease enzyme family and are known to play an essential role in inflammation and programmed cell death. Here is the latest research.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis